Approach to the diagnosis of the uveitides
- PMID: 23668682
- PMCID: PMC3720682
- DOI: 10.1016/j.ajo.2013.03.027
Approach to the diagnosis of the uveitides
Abstract
Purpose: To describe an approach to diagnosing the uveitides, a collection of about 30 separate diseases characterized by intraocular inflammation.
Design: Perspective.
Methods: Integration of clinical approach with a more formal, informatics-derived approach to characterization and a Bayesian approach to laboratory testing.
Results: The patient's uveitis is characterized along several dimensions: course, laterality, anatomic location of the inflammation, morphology, presence of active infection, and the host (age, presence of a systemic disease). Posterior uveitis can be characterized further by whether it is primarily a retinitis, choroiditis, or retinal vasculitis; by whether it is paucifocal or multifocal; and by the morphology of the lesions. This characterization narrows the differential diagnosis to 1 or, at most, a few diseases. Laboratory screening (ie, testing all patients) should be reserved for those diseases that can present as any type of uveitis, whereas targeted testing (ie, testing a subset with specific features) is used selectively. Laboratory testing should be used to identify an infection (which will alter therapy) or a systemic disease that will affect the patient's health. A uveitis that is not one of the established diagnoses is designated as "undifferentiated" with the course, laterality, and anatomic location (eg, undifferentiated bilateral chronic anterior uveitis). We avoid the term "idiopathic" uveitis as most identified noninfectious uveitic diseases are idiopathic, and most systemic diseases associated with uveitis also are idiopathic (eg, juvenile idiopathic arthritis).
Conclusion: This approach should lead to the correct diagnosis of the specific uveitic disease in the large majority of cases without overuse of laboratory testing.
Copyright © 2013 Elsevier Inc. All rights reserved.
Similar articles
-
[Semiology and classification of uveitis].Rev Prat. 1999 Nov 15;49(18):1982-8. Rev Prat. 1999. PMID: 10626482 Review. French.
-
Targeted Medical History and Diagnostic Testing in Uveitis.Klin Monbl Augenheilkd. 2022 May;239(5):654-658. doi: 10.1055/a-1737-4306. Epub 2022 Mar 23. Klin Monbl Augenheilkd. 2022. PMID: 35320872 English, German.
-
Epidemiological profile of non-infectious uveitis from the rheumatologist's perspective: a survey from two tertiary referral centres in Italy.Clin Exp Rheumatol. 2018 Nov-Dec;36(6 Suppl 115):68-73. Epub 2018 Dec 12. Clin Exp Rheumatol. 2018. PMID: 30582503
-
Benefits of Systemic Anti-inflammatory Therapy versus Fluocinolone Acetonide Intraocular Implant for Intermediate Uveitis, Posterior Uveitis, and Panuveitis: Fifty-four-Month Results of the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study.Ophthalmology. 2015 Oct;122(10):1967-75. doi: 10.1016/j.ophtha.2015.06.042. Epub 2015 Aug 20. Ophthalmology. 2015. PMID: 26298715 Free PMC article. Clinical Trial.
-
Uveitis: a strategy for diagnosis.Aust N Z J Ophthalmol. 1987 Aug;15(3):227-41. doi: 10.1111/j.1442-9071.1987.tb00076.x. Aust N Z J Ophthalmol. 1987. PMID: 3314914 Review.
Cited by
-
A Prospective Study of Clinical Features of Anterior Uveitis in Taiwan.J Ophthalmol. 2023 Nov 7;2023:9647418. doi: 10.1155/2023/9647418. eCollection 2023. J Ophthalmol. 2023. PMID: 38025927 Free PMC article.
-
Dexamethasone intravitreal implant for macular edema and some other rare indications in uveitis.Med Int (Lond). 2023 Jul 19;3(4):39. doi: 10.3892/mi.2023.99. eCollection 2023 Jul-Aug. Med Int (Lond). 2023. PMID: 37560325 Free PMC article.
-
Cataract Surgery in Patients With Uveitis Treated With Systemic Therapy in the Multicenter Uveitis Steroid Treatment (MUST) Trial and Follow-up Study: Risk Factors and Outcomes.Am J Ophthalmol. 2023 Oct;254:210-220. doi: 10.1016/j.ajo.2023.06.023. Epub 2023 Jul 3. Am J Ophthalmol. 2023. PMID: 37406846 Free PMC article. Clinical Trial.
-
Current Landscape of Uveitis Specialists in the United States.J Acad Ophthalmol (2017). 2022 Aug 29;14(2):e187-e192. doi: 10.1055/s-0042-1755581. eCollection 2022 Jul. J Acad Ophthalmol (2017). 2022. PMID: 37388168 Free PMC article.
-
Long-term visual acuity outcome of pediatric uveitis patients presenting with severe visual impairment.Sci Rep. 2023 Feb 20;13(1):2919. doi: 10.1038/s41598-023-29159-x. Sci Rep. 2023. PMID: 36807333 Free PMC article.
References
-
- Bloch-Michel E, Nussenblatt RB. International Uveitis Study Group recommendation for the evaluation of intraocular inflammatory disease. Am J Ophthalmol. 1987;103(2):234–235. - PubMed
-
- Smith RE, Nozik RA. Uveitis: A Clinical Approach to Diagnosis and Management. 3rd ed. Lippincott Williams & Wilkins; Michigan: 2003.
-
- Okada AA, Jabs DA. The SUN project. The future is here. Arch Ophthalmol. 2012 in press.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources